Autonomix Medical, Inc. announced its common stock will begin trading on the Nasdaq, Monday, January 29, 2024 at approximately 10:30 am EST under the ticker symbol...
Response Plus Medical (RPM) announced the strategic acquisition of UK-headquartered Prometheus Medical. Prometheus is part of Safeguard Medical. RPM is part of Response Plus Holding PJSC,...
Tourmaline Bio, Inc. announced the closing of its previously-announced underwritten public offering of 5,307,691 shares of its common stock, which includes the full exercise of the...
Lion Street Medical, LLC announce the successful acquisition of Pensar Medical, LLC. The acquisition, finalized in October 2023, brings new leadership to the trusted Pensar Medical...
Thermo Fisher Scientific has promoted Swapnil Ramteke to national business development manager. Prior to this, Swapnil was senior manager, product marketing in the company. In his...
Vera Therapeutics, Inc. announced its plans to commence a public offering, subject to market and other conditions, to issue and sell $200.0 million of shares of...
Checkpoint Therapeutics, Inc. announced that it has entered into a definitive agreement with a single healthcare-dedicated institutional investor for the issuance and sale of an aggregate...
Beckman Coulter Life Sciences announces a strategic partnership with Polycarbin, to drive a paradigm shift in lab sustainability for liquid handling automation plastics. This collaboration combines...
SeaStar Medical Holding Corporation announced that it has entered into a securities purchase agreement with a single institutional investor to purchase 10,840,761 shares of common stock...
Autonomix Medical, Inc. announced the closing of its initial public offering of 2,234,222 shares of common stock priced at $5.00 per share. The gross proceeds to...
CVRx, Inc. announced its financial and operating results for the fourth quarter and full year of 2023, and affirmed its 2024 business outlook. Recent highlights Total...
GRI Bio, Inc. announced that the board of directors of the Company approved a 1-for-7 reverse stock split of the Company’s common stock. The Reverse Split...
ObjectiveHealth announced that it has secured a strategic growth investment from Vitruvian Partners, a leading global growth-focused investment firm. ObjectiveHealth is an innovator in clinical research,...
Panbela Therapeutics, Inc. announced the pricing of a public offering of (i) 4,375,000 shares of its common stock or pre-funded warrants in lieu thereof and (ii)...
Bruker Corporation announced a definitive agreement for the acquisition of Chemspeed Technologies AG. Chemspeed. The Chemspeed acquisition accelerates Bruker’s entry into lab automation, digitalization and scientific...
Copyright © 2024 Medical Buyer